Functional loss of I kappa B epsilon leads to NF-kappa B deregulation in aggressive chronic lymphocytic leukemia

L Mansouri, LA Sutton, V Ljungstrom, S Bondza, L Arngarden, S Bhoi, J Larsson, D Cortese, A Kalushkova, K Plevova, E Young, R Gunnarsson, E Falk-Sorqvist, P Lonn, Alice Muggen, XJ Yan, B Sander, G Enblad, KE Smedby, G JuliussonC Belessi, J Rung, N Chiorazzi, JC Strefford, Ton Langerak, S Pospisilova, F Davi, M Hellstrom, H Jernberg-Wiklund, P Ghia, O Soderberg, K Stamatopoulos, M Nilsson, R Rosenquist

Research output: Contribution to journalArticleAcademicpeer-review

88 Citations (Scopus)
15 Downloads (Pure)


NF-kappa B is constitutively activated in chronic lymphocytic leukemia (CLL); however, the implicated molecular mechanisms remain largely unknown. Thus, we performed targeted deep sequencing of 18 core complex genes within the NF-kappa B pathway in a discovery and validation CLL cohort totaling 315 cases. The most frequently mutated gene was NFKBIE (21/315 cases; 7%), which encodes I kappa B epsilon, a negative regulator of NF-kappa B in normal B cells. Strikingly, 13 of these cases carried an identical 4-bp frameshift deletion, resulting in a truncated protein. Screening of an additional 377 CLL cases revealed that NFKBIE aberrations predominated in poor-prognostic patients and were associated with inferior outcome. Minor subclones and/or clonal evolution were also observed, thus potentially linking this recurrent event to disease progression. Compared with wild-type patients, NFKBIE-deleted cases showed reduced I kappa B epsilon protein levels and decreased p65 inhibition, along with increased phosphorylation and nuclear translocation of p65. Considering the central role of B cell receptor (BcR) signaling in CLL pathobiology, it is notable that I kappa B epsilon loss was enriched in aggressive cases with distinctive stereotyped BcR, likely contributing to their poor prognosis, and leading to an altered response to BcR inhibitors. Because NFKBIE deletions were observed in several other B cell lymphomas, our findings suggest a novel common mechanism of NF-kappa B deregulation during lymphomagenesis.
Original languageUndefined/Unknown
Pages (from-to)833-843
Number of pages11
JournalJournal of Experimental Medicine
Issue number6
Publication statusPublished - 2015

Research programs

  • EMC MM-02-72-03

Cite this